We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$48B
AUM Growth
-$1.59B
(-3.2%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$60.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.8M |
| 3 |
Mastercard
MA
|
+$43.1M |
| 4 |
Analog Devices
ADI
|
+$40.3M |
| 5 |
Broadcom
AVGO
|
+$40.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$92.3M |
| 2 |
NVIDIA
NVDA
|
+$92.1M |
| 3 |
Eli Lilly
LLY
|
+$80.8M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$74.2M |
| 5 |
Microsoft
MSFT
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.14% |
| 2 | Financials | 15.08% |
| 3 | Healthcare | 14.69% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLNX
226
DELISTED
Xilinx Inc
XLNX
| $33.2M | 0.07% |
220,090
-78,713
| -26% | -$11.5M |
|
227
Kroger
KR
$35.5B
| $33.1M | 0.07% |
818,154
-197,144
| -19% | -$8.28M |
|
228
Bread Financial
BFH
$4.29B
| $33M | 0.07% |
410,460
-14,028
| -3% | -$1.08M |
|
|
KRTX
229
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $33M | 0.07% |
269,519
-16,787
| -6% | -$1.94M |
|
230
Church & Dwight Co
CHD
$23.4B
| $32.9M | 0.07% |
398,938
-30,267
| -7% | -$2.57M |
|
231
VeriSign
VRSN
$24.8B
| $32.9M | 0.07% |
160,276
+7,624
| +5% | +$1.67M |
|
232
United Parcel Service
UPS
$96B
| $32.3M | 0.07% |
177,368
-47,127
| -21% | -$9.3M |
|
233
Booking.com
BKNG
$145B
| $32.3M | 0.07% |
339,675
+12,575
| +4% | +$1.13M |
|
234
Alnylam Pharmaceuticals
ALNY
$37.2B
| $31.8M | 0.07% |
168,599
-4,144
| -2% | -$777K |
|
235
Hartford Financial Services
HIG
$38.4B
| $31.8M | 0.07% |
453,058
-608,801
| -57% | -$40.2M |
|
236
United Rentals
URI
$70.2B
| $31.8M | 0.07% |
90,531
-14,760
| -14% | -$4.95M |
|
237
HealthEquity
HQY
$8.28B
| $31.3M | 0.07% |
483,723
+7,488
| +2% | +$520K |
|
238
TE Connectivity
TEL
$60.2B
| $31.2M | 0.07% |
227,465
+74,896
| +49% | +$10.8M |
|
239
CSX Corp
CSX
$96B
| $30.9M | 0.06% |
1,038,700
+240,550
| +30% | +$7.7M |
|
240
Moderna
MRNA
$22.1B
| $30.7M | 0.06% |
79,857
+65,392
| +452% | +$24.1M |
|
241
Cognizant
CTSH
$22.3B
| $30.7M | 0.06% |
413,825
-63,986
| -13% | -$4.72M |
|
242
Simon Property Group
SPG
$75.1B
| $30.6M | 0.06% |
235,444
+15,235
| +7% | +$1.98M |
|
243
Hewlett Packard
HPE
$63.8B
| $30.5M | 0.06% |
2,138,585
-39,613
| -2% | -$572K |
|
244
International Flavors & Fragrances
IFF
$19.5B
| $30.4M | 0.06% |
227,160
-26,808
| -11% | -$3.94M |
|
245
KLA
KLAC
$266B
| $30.2M | 0.06% |
902,700
+261,370
| +41% | +$8.73M |
|
246
Ingersoll Rand
IR
$33.1B
| $30M | 0.06% |
595,829
-679,388
| -53% | -$34.6M |
|
247
Cognex
CGNX
$10.2B
| $30M | 0.06% |
374,134
-1,386
| -0.4% | -$119K |
|
248
Wayfair
W
$12.5B
| $30M | 0.06% |
117,369
+104,804
| +834% | +$29.6M |
|
249
Apollo Global Management
APO
$71.6B
| $29.9M | 0.06% |
486,115
| – | – |
|
250
Hyatt Hotels
H
$18B
| $29.9M | 0.06% |
387,952
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.
- Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
- Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
- Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
- Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
- Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
- Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
- Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.
Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.